Alexandra J Lansky

Summary

Affiliation: Cardiovascular Research Foundation
Country: USA

Publications

  1. ncbi request reprint Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation
    Alexandra J Lansky
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 39:274-80. 2002
  2. doi request reprint Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial
    Alexandra J Lansky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    Catheter Cardiovasc Interv 74:719-27. 2009
  3. doi request reprint Quantitative angiographic methods for bifurcation lesions: a consensus statement from the European Bifurcation Group
    Alexandra Lansky
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    Catheter Cardiovasc Interv 73:258-66. 2009
  4. ncbi request reprint Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft
    Alexandra J Lansky
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:370-4. 2006
  5. ncbi request reprint Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age
    Alexandra J Lansky
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 93:916-9. 2004
  6. ncbi request reprint Outcomes of percutaneous and surgical revascularization in women
    Alexandra J Lansky
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Prog Cardiovasc Dis 46:305-19. 2004
  7. ncbi request reprint Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) tr
    Alexandra J Lansky
    College of Physicians and Surgeons, Columbia University, and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Circulation 111:1611-8. 2005
  8. ncbi request reprint Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial
    Alexandra J Lansky
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E 59th St, 6th Floor, New York, NY 10022 1112, USA
    Circulation 109:1948-54. 2004
  9. doi request reprint Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial)
    Alexandra J Lansky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 103:1196-203. 2009
  10. ncbi request reprint Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitations
    Alexandra J Lansky
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, Lenox Hill Hospital, New York, New York 10022, USA
    Am J Cardiol 89:4B-9B. 2002

Collaborators

Detail Information

Publications112 found, 100 shown here

  1. ncbi request reprint Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation
    Alexandra J Lansky
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 39:274-80. 2002
    ....
  2. doi request reprint Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial
    Alexandra J Lansky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    Catheter Cardiovasc Interv 74:719-27. 2009
    ..We evaluated the role of gender on clinical and angiographic results of the everolimus-eluting stent in the SPIRIT III trial...
  3. doi request reprint Quantitative angiographic methods for bifurcation lesions: a consensus statement from the European Bifurcation Group
    Alexandra Lansky
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    Catheter Cardiovasc Interv 73:258-66. 2009
    ....
  4. ncbi request reprint Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft
    Alexandra J Lansky
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:370-4. 2006
    ..The CSG may be a reliable and highly effective treatment option for sealing coronary perforations complicating percutaneous coronary interventions...
  5. ncbi request reprint Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age
    Alexandra J Lansky
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 93:916-9. 2004
    ....
  6. ncbi request reprint Outcomes of percutaneous and surgical revascularization in women
    Alexandra J Lansky
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Prog Cardiovasc Dis 46:305-19. 2004
    ..This paper reviews the specific pathophysiology of CAD in women as it influences outcome and current interventional and surgical treatment modalities and outcomes for stable and unstable coronary artery syndromes...
  7. ncbi request reprint Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) tr
    Alexandra J Lansky
    College of Physicians and Surgeons, Columbia University, and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Circulation 111:1611-8. 2005
    ..Whether contemporary interventional treatment strategies have improved outcomes for women compared with men is unknown...
  8. ncbi request reprint Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial
    Alexandra J Lansky
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E 59th St, 6th Floor, New York, NY 10022 1112, USA
    Circulation 109:1948-54. 2004
    ..The DELIVER trial was a prospective, randomized, blinded, multicenter clinical evaluation of the non-polymer-based paclitaxel-coated ACHIEVE stent compared with the stainless steel Multi-Link (ML) PENTA stent...
  9. doi request reprint Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial)
    Alexandra J Lansky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 103:1196-203. 2009
    ..In women, bivalirudin monotherapy compared with a GPI-based strategy resulted in significantly decreased bleeding but similar rates of 1-year composite ischemia and mortality...
  10. ncbi request reprint Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitations
    Alexandra J Lansky
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, Lenox Hill Hospital, New York, New York 10022, USA
    Am J Cardiol 89:4B-9B. 2002
    ..Angiographic methods and criteria for assessing disease progression each have distinct advantages and disadvantages, which accounts for the methodologic diversity seen in clinical trials...
  11. doi request reprint Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 54:1293-302. 2009
    ..We assessed the incidence, predictors, and outcomes of gastrointestinal bleeding (GIB) in patients with acute coronary syndromes (ACS)...
  12. doi request reprint A risk score to predict bleeding in patients with acute coronary syndromes
    Roxana Mehran
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
    J Am Coll Cardiol 55:2556-66. 2010
    ..The aim of this study was to develop a practical risk score to predict the risk and implications of major bleeding in acute coronary syndromes (ACS)...
  13. doi request reprint Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial)
    Kenichi Tsujita
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 105:1385-94. 2010
    ..Paradoxically, in this post hoc analysis, the reductions in major bleeding and mortality in ST elevation myocardial infarction afforded by bivalirudin occurred primarily in patients without baseline anemia...
  14. doi request reprint Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial)
    Kenji Goto
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 108:1387-94. 2011
    ..Bivalirudin monotherapy compared to UFH plus a GPI decreased major bleeding regardless of smoking status but may have different effects on individual components of ischemic events...
  15. doi request reprint Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial In
    Adam J Saltzman
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    JACC Cardiovasc Interv 4:1011-9. 2011
    ..This study sought to investigate the impact of chronic kidney disease (CKD) in patients undergoing percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) with different antithrombotic strategies...
  16. doi request reprint Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY)
    Roxana Mehran
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
    JACC Cardiovasc Interv 2:748-57. 2009
    ....
  17. doi request reprint Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction
    George D Dangas
    Cardiovascular Institute, Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    Circulation 123:1745-56. 2011
    ..Concerns persist regarding the risk of stent thrombosis in the setting of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction...
  18. doi request reprint The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale
    Roxana Mehran
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
    Am Heart J 156:44-56. 2008
    ..Newer pharmacologic agents and drug-eluting stents may address both of these issues...
  19. doi request reprint Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent int
    Roxana Mehran
    Department of Cardiology, Mount Sinai Medical Center, New York, New York, USA
    JACC Cardiovasc Interv 4:654-64. 2011
    ..This study sought to develop a risk score predictive of bleeding in patients undergoing percutaneous coronary intervention (PCI) and to investigate the impact of bleeding on subsequent mortality...
  20. doi request reprint Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
    JACC Cardiovasc Interv 2:624-32. 2009
    ..We sought to determine the relationship between red blood cell (RBC) transfusion and clinical outcomes in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)...
  21. ncbi request reprint Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era
    Tereza Pucelikova
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    Am J Cardiol 101:63-8. 2008
    ..025). In conclusion, our data show that patients with SVG lesions remain a high-risk subgroup with worse outcomes after percutaneous coronary intervention compared with native vessel disease even in the era of drug-eluting stents...
  22. ncbi request reprint Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 44:547-53. 2004
    ..We sought to investigate the impact of anemia in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI)...
  23. ncbi request reprint Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 99:1055-61. 2007
    ..03, 95% CI 1.00 to 1.06, p = 0.055) at 1 year. In conclusion, a higher baseline platelet count in patients with AMI is a powerful independent predictor of death and reinfarction within the first year after primary PCI...
  24. ncbi request reprint Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention
    Eugenia Nikolsky
    Cardiovascular Research Foundation, and Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 94:300-5. 2004
    ..Contrast-induced nephropathy was among the independent predictors of a 1-year mortality rate (OR 2.75, p <0.001)...
  25. doi request reprint Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial
    Alexandra J Lansky
    Columbia University Medical Center, Department of Cardiology, Cardiovascular Research Foundation, New York, New York 10022, USA
    Catheter Cardiovasc Interv 72:917-24. 2008
    ..The aim of this article is to examine whether clopidogrel and ticlopidine treatments produce similar clinical outcomes for patients receiving primary stenting for acute myocardial infarction (AMI)...
  26. ncbi request reprint Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 95:355-9. 2005
    ..Plaque rupture morphology is associated with higher periprocedural CK-MB release and worse 1-year clinical outcome in patients treated with coronary stenting...
  27. ncbi request reprint Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale
    Gregg W Stone
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
    Am Heart J 148:764-75. 2004
    ..Pilot trials suggest that the thrombin-specific anticoagulant bivalirudin may improve clinical outcomes in ACS...
  28. ncbi request reprint Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation
    Hideo Takebayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    Circulation 110:3430-4. 2004
    ..Little is known about causes of intimal hyperplasia (IH) after sirolimus-eluting stent (SES) implantation...
  29. doi request reprint Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials
    Jacob A Doll
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, USA
    J Interv Cardiol 22:453-9. 2009
    ..The lack of a specific counteragent to bivalirudin may complicate the management of patients with coronary artery (CA) perforation during percutaneous coronary intervention (PCI)...
  30. doi request reprint Intravascular ultrasound comparison of the retrograde versus antegrade approach to percutaneous intervention for chronic total coronary occlusions
    Kenichi Tsujita
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    JACC Cardiovasc Interv 2:846-54. 2009
    ..We sought to evaluate the results of the antegrade versus retrograde chronic total occlusion (CTO) technique with intravascular ultrasound (IVUS) imaging...
  31. doi request reprint Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
    Roxana Mehran
    Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
    Lancet 374:1149-59. 2009
    ..Here, we assess whether these initial benefits were maintained at 1 year of follow-up...
  32. doi request reprint Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis
    Young Hak Kim
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 101:801-6. 2008
    ..However, bifurcation stenosis remains a significant predictor of unfavorable clinical outcome...
  33. ncbi request reprint An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY 10022, USA
    J Invasive Cardiol 19:208-13. 2007
    ..We evaluated short-term prognosis and resource utilization of consecutive patients treated with percutaneous coronary intervention (PCI) as a function of fluoroscopy time...
  34. doi request reprint Plaque shift and distal embolism in patients with acute myocardial infarction: a volumetric intravascular ultrasound analysis from the HORIZONS-AMI trial
    Xiaofan Wu
    Columbia University Medical Center, New York 10022, USA
    Catheter Cardiovasc Interv 82:203-9. 2013
    ..Vessel expansion and axial plaque redistribution or distal plaque embolization contribute to the increase in lumen dimensions after stent implantation...
  35. ncbi request reprint Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Lancet 369:907-19. 2007
    ..The aim of this study was to assess anticoagulation with the direct thrombin inhibitor bivalirudin during percutaneous coronary intervention in individuals with moderate and high-risk acute coronary syndromes...
  36. doi request reprint Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes
    Usman Baber
    Mount Sinai Medical Center, New York, New York, USA
    JACC Cardiovasc Imaging 5:S53-61. 2012
    ..This study sought to evaluate the impact of chronic kidney disease (CKD) on coronary atherosclerotic plaque composition, morphology, and outcomes in patients with acute coronary syndromes (ACS)...
  37. doi request reprint Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial
    Philippe Genereux
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    EuroIntervention 7:905-16. 2011
    ..There is a paucity of data comparing the TR approach with the TF approach in patients with STEMI treated with primary PCI and contemporary anticoagulant regimens...
  38. doi request reprint Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent
    Bimmer E Claessen
    New York Presbyterian Hospital, Columbia University, New York, NY, USA
    JACC Cardiovasc Interv 4:1209-15. 2011
    ..The aim of this study was to investigate the impact of reference vessel diameter (RVD) and lesion length (LL) on the relative safety and efficacy of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES)...
  39. doi request reprint Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial
    Jiro Aoki
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    Circulation 119:687-98. 2009
    ..The clinical and angiographic predictors of early (<30 days) stent thrombosis (ST) have not been reported in high-risk patients with acute coronary syndromes...
  40. doi request reprint Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction
    Gregg W Stone
    Columbia University Medical Center and New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 360:1946-59. 2009
    ....
  41. doi request reprint Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction
    LeRoy E Rabbani
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, New York 10032, USA
    J Interv Cardiol 22:378-84. 2009
    ....
  42. doi request reprint Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial
    Kenji Goto
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    JACC Cardiovasc Interv 4:769-77. 2011
    ....
  43. doi request reprint 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial
    Gregg W Stone
    Department of Medicine, Division of Cardiology, Columbia University, Medical Center New York Presbyterian Hospital, Cardiovascular Research Foundation, New York 10022, USA
    JACC Cardiovasc Interv 4:300-9. 2011
    ..We sought to evaluate the utility of the JOSTENT polytetrafluoroethylene (PTFE) stent-graft (Jomed GmbH, Rangendingen, Germany) in patients with diseased saphenous vein grafts (SVGs) undergoing percutaneous coronary intervention (PCI)...
  44. ncbi request reprint Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis
    Kazuyuki Shirai
    Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
    Am J Cardiol 92:1409-13. 2003
    ..In matched lesions, beta and gamma VBT achieved similar reductions in treated segment restenosis and recurrent lesion length compared with placebo...
  45. doi request reprint Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study
    Tomotaka Dohi
    Columbia University Medical Center, New York, New York, USA
    JACC Cardiovasc Imaging 6:908-16. 2013
    ..The purpose of this study was to determine the clinical impact of non-fibroatheroma lesion phenotype in patients presenting with an acute coronary syndrome (ACS)...
  46. ncbi request reprint Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation
    Hideo Takebayashi
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 95:498-502. 2005
    ....
  47. ncbi request reprint Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound
    Masashi Kimura
    The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:436-42. 2006
    ..Although most ISAs after SES implantation do not resolve completely, the incidence of restenosis or thrombosis is not affected...
  48. ncbi request reprint Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 42:1900-5. 2003
    ..We sought to determine the impact of aggressive stent expansion on creatine kinase-MB isoenzyme (CK-MB) release and clinical restenosis...
  49. doi request reprint Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy
    Kenji Goto
    Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022, USA
    Circulation 121:853-62. 2010
    ..We sought to assess the predictors of adverse cardiac events in patients with acute coronary syndrome assigned to medical management...
  50. doi request reprint Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial
    Alexandra J Lansky
    Columbia University Medical Center, New York, NY 10022, USA
    Circ Cardiovasc Interv 3:308-16. 2010
    ..We sought to identify the clinical and angiographic predictors of cardiac ischemic events in patients with ACSs treated with an early invasive strategy...
  51. ncbi request reprint Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Am J Cardiol 93:1536-9. 2004
    ..These 2 conditions are associated with adverse in-hospital and 1-year outcomes and independently predict early and 1-year mortality...
  52. ncbi request reprint Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)
    Yoshihiro Tsuchiya
    The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 98:464-9. 2006
    ..The EES appears to be effective for treatment of de novo coronary lesions in decreasing neointimal proliferation at 6-month follow-up compared with BMSs, regardless of vessel size...
  53. doi request reprint Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation
    Xuebo Liu
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    JACC Cardiovasc Interv 2:997-1004. 2009
    ..We used intravascular ultrasound (IVUS) to assess incidence, predictors, morphology, and angiographic findings of edge dissections after drug-eluting stent (DES) implantation...
  54. ncbi request reprint Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of P
    George D Dangas
    Division of Cardiology, Mount Sinai Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York Electronic address
    JACC Cardiovasc Interv 6:914-22. 2013
    ..This study sought to investigate whether the everolimus-eluting stent (EES) is superior to the paclitaxel-eluting stent (PES) with respect to long-term individual clinical outcomes...
  55. ncbi request reprint The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention
    Adam J Saltzman
    Cardiovascular Medicine and the Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA
    J Invasive Cardiol 22:2-6. 2010
    ..We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI)...
  56. ncbi request reprint Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries
    Dale T Ashby
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascualr Institute, New York, New York 10022, USA
    Am J Cardiol 89:1162-6. 2002
    ..A stenting strategy for proximal LAD stenoses appears to attenuate the differences of clinical restenosis noted after non-stent PCI...
  57. ncbi request reprint Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis
    Koichi Sano
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, USA
    Am J Cardiol 98:1559-62. 2006
    ....
  58. doi request reprint Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial
    George D Dangas
    Department of Cardiology, Mount Sinai Medical Center, New York, New York 10029, USA
    J Am Coll Cardiol 59:1752-9. 2012
    ....
  59. ncbi request reprint Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions
    Costantino O Costantini
    Cardiovascular Research Foundation, Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, New York, NY 10022, USA
    J Am Coll Cardiol 41:1725-31. 2003
    ..We analyzed the effects of vascular brachytherapy (VBT) on ostial in-stent restenosis (ISR)...
  60. doi request reprint Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy)
    So Yeon Choi
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 109:455-60. 2012
    ....
  61. ncbi request reprint Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:1171-6. 2003
    ..Therefore, there does not appear to be any "downside" to aggressive stent implantation strategies in small vessels. In contrast, IVUS allows maximization of final lumen dimensions to minimize clinical restenosis...
  62. ncbi request reprint Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score
    Amir Halkin
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 45:1397-405. 2005
    ..We sought to develop a simple risk score for predicting mortality after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)...
  63. ncbi request reprint Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10021, USA
    Circulation 109:1085-8. 2004
    ..We used intravascular ultrasound (IVUS) to evaluate recurrence after sirolimus-eluting stent (SES) implantation treatment of in-stent restenosis (ISR)...
  64. doi request reprint The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial
    Xiaofan Wu
    Columbia University Medical Center, New York, New York, USA
    JACC Cardiovasc Interv 4:495-502. 2011
    ..The aim of this study was to understand the impact of attenuated plaque on distal embolization during stent implantation in patients with acute myocardial infarction (AMI)...
  65. ncbi request reprint A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation
    Roxana Mehran
    Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York 10022, USA
    J Am Coll Cardiol 44:1393-9. 2004
    ..We sought to develop a simple risk score of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI)...
  66. doi request reprint Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy
    Akiko Maehara
    Columbia University Medical Center, New York, NY 10022, USA
    Circulation 120:1875-82. 2009
    ....
  67. ncbi request reprint Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts
    Koichi Sano
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 97:1463-6. 2006
    ..These IVUS differences may account for some of the location-specific differences in interventional complications...
  68. ncbi request reprint Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis
    Ricardo A Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    J Am Coll Cardiol 46:599-605. 2005
    ..We report intravascular ultrasound (IVUS) findings after crush-stenting of bifurcation lesions...
  69. ncbi request reprint Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction
    Amir Halkin
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:325-31. 2005
    ..Simple clinical and angiographic features readily available at the time of primary angioplasty also predict convalescent LVEF and are thus of prognostic utility...
  70. doi request reprint 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents
    Adriano Caixeta
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 54:894-902. 2009
    ..Five-year clinical follow-up has been scheduled per protocol by the 4 Cypher (Cordis/Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) versus bare-metal stent (BMS) randomized trials...
  71. ncbi request reprint Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%
    Makoto Hirose
    Cardiovascular Research Foundation, New York, NY 10021, USA
    Am J Cardiol 92:141-5. 2003
    ..7) were similar. Negative remodeling is frequently observed in lesions with intermediate stenosis. This suggests that negative remodeling occurs early in lesion formation...
  72. doi request reprint Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial
    Gregg W Stone
    Columbia University Medical Center, The Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022, USA
    JAMA 299:1903-13. 2008
    ....
  73. doi request reprint Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease
    Gregg W Stone
    Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 362:1663-74. 2010
    ..Previous studies have established the superiority of coronary everolimus-eluting stents over paclitaxel-eluting stents with respect to angiographic findings. However, these trials were not powered for superiority in clinical end points...
  74. ncbi request reprint Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial
    Costantino O Costantini
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 91:1261-5. 2003
  75. ncbi request reprint Relation between the degree of procedural anticoagulation and complications after coronary stent implantation
    Dale T Ashby
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:319-22. 2003
    ..High levels of procedural anticoagulation with heparin were found to increase hemorrhagic complications without improving clinical or angiographic outcomes...
  76. ncbi request reprint New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registry
    Alexandra J Lansky
    Cardiac Catheterization Laboratory and the Women s Cardiac Health Initiative, Lenox Hill Hospital, New York City, NY 10022, USA
    Epidemiology 13:S46-51. 2002
    ..To gain insight into the outcome of women after new-device angioplasty, we reviewed the early and late clinical outcome of 7,372 patients undergoing new-device angioplasty between 1991 and 1996 at the Washington Hospital Center...
  77. ncbi request reprint Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings
    Jiro Aoki
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY, USA
    Am J Cardiol 101:58-62. 2008
    ..In conclusion, the incidence of DES and BMS overlap stenting is rare in daily practice, but this procedure is associated with a high rate of target vessel revascularization...
  78. ncbi request reprint Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction
    Eugenia Nikolsky
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:474-81. 2005
    ..0% vs 3.9%, p = 0.03) in patients who developed thrombocytopenia. In conclusion, thrombocytopenia that develops after primary PCI for AMI, although uncommon, is associated with increased hemorrhagic complications and decreased survival...
  79. ncbi request reprint Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease
    Alexandra J Lansky
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 45:1180-5. 2005
    ..We sought to determine whether gender influences the results of paclitaxel-eluting stent implantation...
  80. ncbi request reprint Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 89:976-9. 2002
  81. ncbi request reprint Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapy
    Costantino O Costantini
    Cardiovascular Research Foundation, New York, New York 10021, USA
    Am J Cardiol 92:1214-7. 2003
    ....
  82. doi request reprint Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization a
    Ning Guo
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, 10022, USA
    Circulation 122:1077-84. 2010
    ..The incidence and mechanisms of acute and late stent malapposition after primary stent implantation in ST-segment elevation myocardial infarction remain unclear...
  83. ncbi request reprint Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon
    Jose de Ribamar Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 100:812-7. 2007
    ..In conclusion, in this observational, nonrandomized study, pretreatment with the AngioSculpt balloon enhanced stent expansion and minimized the difference between predicted and achieved stent dimensions...
  84. ncbi request reprint Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions
    Ricardo A Costa
    The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 98:443-6. 2006
    ..14 +/- 0.45 vs 0.40 +/- 0.41 mm, p = 0.004). In-stent restenosis was 3.9% in the Biolimus stent group versus 7.7% in the control group (p = 0.40). There was no exaggerated hyperplasia at the proximal and/or distal edge of the stent...
  85. ncbi request reprint Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction
    Costantino O Costantini
    Cardiovascular Research Foundation and Lenox Hill Hospital, New York, New York, USA
    J Am Coll Cardiol 44:305-12. 2004
    ..We sought to determine the prognostic importance of myocardial reperfusion after various contemporary interventional strategies in patients with acute myocardial infarction (AMI)...
  86. ncbi request reprint Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending artery
    Ioannis Iakovou
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 90:885-7. 2002
  87. ncbi request reprint Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques
    Kenichi Fujii
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 96:352-7. 2005
    ..In conclusion, ruptured plaques are associated with a larger number of calcium deposits within an arc of <90 degrees , a larger number of deep calcium deposits, and a remodeling index...
  88. doi request reprint SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Am Heart J 158:520-526.e2. 2009
    ..We therefore designed a large-scale randomized trial without angiographic follow-up to further assess the differences between these 2 stent platforms...
  89. ncbi request reprint Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)
    Ricardo A Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    Am J Cardiol 95:113-6. 2005
    ..There was 1 in-stent and 1 in-segment (proximal edge) restenosis in the metallic stent group. There was no stent thrombosis or aneurysm formation at follow-up in either group...
  90. ncbi request reprint Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)
    Thosaphol Limpijankit
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 92:315-8. 2003
    ..e., drug-eluting stents) are available. Shorter time from brachytherapy to radiation failure and late thrombosis after brachytherapy were independent predictors of adverse events...
  91. ncbi request reprint Late vascular response to repeat stenting for in-stent restenosis with and without radiation: an intravascular ultrasound volumetric analysis
    Yoshihiro Morino
    Center for Research in Cardiovascular Interventions, Stanford University Medical Center, Stanford, CA, USA
    Circulation 105:2465-8. 2002
    ..3% and C=58.9%) than in re-stented segments in placebo patients (B=27.3% and C 26.8%) and non-re-stented segments in irradiated patients...
  92. ncbi request reprint Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis
    Ross Prpic
    Harvard Clinical Research Institute, Boston, Mass 02215, USA
    Circulation 106:2340-5. 2002
    ..The short- and long-term outcomes of repeat percutaneous intervention in this population have not been characterized...
  93. ncbi request reprint Delivered dose and vascular response after beta-radiation for in-stent restenosis: retrospective dosimetry and volumetric intravascular ultrasound analysis
    Yoshihiro Morino
    Center for Research in Cardiovascular Interventions, Stanford University Medical Center, Stanford, Calif 94305 5637, USA
    Circulation 106:2334-9. 2002
    ..The aims of this study were to investigate the effect of actual delivered dose on vascular changes and to test the appropriateness of the current dose prescription...
  94. ncbi request reprint Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis
    Jeffrey J Popma
    Interventional Cardiology, Brigham and Women s Hospital, Boston, Mass 02115, USA
    Circulation 106:1090-6. 2002
    ..We report the first multicenter, blinded, and randomized trial of intracoronary radiation with the use of a 90Sr/90Y beta-source for the treatment of in-stent restenosis...
  95. ncbi request reprint Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results
    Ulrich Gercken
    Department of Cardiology and Angiology, Heart Center, Siegburg, Siegburg, Germany
    Catheter Cardiovasc Interv 56:353-60. 2002
    ..Covered stents such as the JoMed coronary stent graft may become essential for bailout treatment of coronary perforations...
  96. ncbi request reprint Prospective, multicenter study of thrombectomy in patients with acute myocardial infarction: the X-Tract AMI registry
    John J Young
    Swedish Heart and Vascular Institute, Seattle, Washington, USA
    J Interv Cardiol 20:44-50. 2007
    ..Thrombectomy prior to intervention may decrease thromboembolic complications and improve outcomes...
  97. ncbi request reprint A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2])
    Richard E Kuntz
    Brigham and Women s Hospital, Boston, Massachusetts 02215, USA
    Am J Cardiol 89:326-30. 2002
  98. ncbi request reprint Five-year clinical and angiographic follow-up after intracoronary iridium-192 radiation therapy
    Jose A Condado
    Department of Cardiology Hospital Miguel Perez Carreno, Centro Medico, Caracas, Venezuela
    Cardiovasc Radiat Med 3:74-81. 2002
    ..The outcome of these patients is presented and discussed...
  99. ncbi request reprint Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial
    Matthews Chacko
    Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Am Heart J 151:1032.e1-7. 2006
    ..The REPLACE-2 trial demonstrated that bivalirudin with provisional glycoprotein IIb/IIIa (GpIIb-IIIa) blockade is noninferior to heparin with planned GpIIb-IIIa blockade during PCI, with regard to ischemic and bleeding end points...
  100. ncbi request reprint Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial
    Hideaki Kaneda
    Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California 94305, USA
    J Interv Cardiol 19:376-80. 2006
    ....
  101. ncbi request reprint Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent
    Alexandre Abizaid
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    Am J Cardiol 99:1403-8. 2007
    ..The inhibition of neointima formation as measured by follow-up angiography and IVUS after 4 months suggests therapeutic potential for the reduction of restenosis...